[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 1994

The Protean Manifestations of Human Papillomavirus InfectionNew Facies of an Old Foe: A Clinical Perspective

Author Affiliations

Department of Dermatology University of Minnesota Medical School Minneapolis, MN 55455

Arch Dermatol. 1994;130(11):1429-1430. doi:10.1001/archderm.1994.01690110095017

CUTANEOUS WARTS are one of the most common maladies treated by the clinical dermatologist. Although all types of warts represent a therapeutic challenge, plantar warts remain a particular vexation. Often unresponsive to therapy, a variety of therapeutic techniques have been used to assault this often implacable foe. Clinicians, after decades of observation, have classified plantar warts into a variety of types: deep (myrmecia), common, mosaic, and endophytic. Molecular studies have revealed that different clinical varieties of warts are associated with specific human papillomavirus (HPV) types. The following HPV types are associated with their respective clinical entities: HPV-1 with deep plantar warts, HPV-2 and HPV-4 with common and mosaic warts, and HPV-4 with endophytic warts.1 More recently, two new HPV types have been associated with plantar warts: HPV-65 which has been associated with a pigmented verrucous plantar wart, and HPV-63 which has been associated with whitish, punctate, keratotic warts showing

First Page Preview View Large
First page PDF preview
First page PDF preview